4.6 Article

Bicyclic Chalcones as Mitotic Inhibitors for Overcoming Androgen Receptor-Independent and Multidrug-Resistant Prostate Cancer

Related references

Note: Only part of the references are listed.
Review Chemistry, Medicinal

Naphthalene, a versatile platform in medicinal chemistry: Sky-high perspective

Subhajit Makar et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

5 '-Chloro-2,2 '-dihydroxychalcone and related flavanoids as treatments for prostate cancer

Yohei Saito et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Chemistry, Multidisciplinary

Chalcone: A Privileged Structure in Medicinal Chemistry

Chunlin Zhuang et al.

CHEMICAL REVIEWS (2017)

Article Biochemistry & Molecular Biology

Triethylated chromones with substituted naphthalenes as tubulin inhibitors

Kyoko Nakagawa-Goto et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Development of a Novel Class of Tubulin Inhibitor from Desmosdumotin B with a Hydroxylated Bicyclic B-Ring

Kyoko Nakagawa-Goto et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Review Chemistry, Medicinal

Flavonoids: Promising anticancer agents

WY Ren et al.

MEDICINAL RESEARCH REVIEWS (2003)

Article Chemistry, Organic

Mechanistic approach to the cyclization reaction of a 2 '-hydroxychalcone analogue with light and solvent

K Kaneda et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2003)

Review Oncology

The development of androgen-independent prostate cancer

BJ Feldman et al.

NATURE REVIEWS CANCER (2001)